Jun 09, 2023
6:5
For every 5 shares held, investors received 6. The price per share adjusted from $31.63 to $26.36.
The split itself did not change the total investment value.
DaShenLin Pharmaceutical Group Co., Ltd. Class A (SSE:603233) operates in the Drugstore chains industry.
DaShenLin Pharmaceutical Group Co., Ltd. Class A company overviewDaShenLin Pharmaceutical Group Co., Ltd. Class A's most recent stock split was on June 9, 2023. It was a 6-for-5 forward split, so shareholders received 6 shares for every 5 they held.
DaShenLin Pharmaceutical Group Co., Ltd. Class A (SSE:603233) has split its stock 5 times: a 13-for-10 split on May 30, 2019, a 6-for-5 split on June 17, 2020, a 6-for-5 split on June 10, 2021, a 6-for-5 split on June 13, 2022, and a 6-for-5 split on June 9, 2023.
DaShenLin Pharmaceutical Group Co., Ltd. Class A has split its stock 5 times. This history records 5 forward splits between May 30, 2019 and June 9, 2023.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In DaShenLin Pharmaceutical Group Co., Ltd. Class A's 6-for-5 split on June 9, 2023, every 5 shares became 6 shares.
DaShenLin Pharmaceutical Group Co., Ltd. Class A has not announced a new split in our records. Its most recent split was on June 9, 2023, 3 years ago. Companies announce splits in advance, and any new SSE:603233 split will appear on this page.
Already premium?